Novo Nordisk shares fell 8% after Eli Lilly reported positive trial results for its weight loss drug, orforglipron, affecting the healthcare sector. Novo Nordisk's shares dropped t...
Deutsche Bank AG's shares fell over 6% after a disappointing earnings report, showing an 8% revenue increase to €7.2 billion but a sharp net profit decrease to €337 million, raisin...
Novo Nordisk's shares dropped over 2% after a preprint study linked Ozempic to a rare vision condition. The study, by scholars from Norway and Denmark, found Ozempic users were twi...
